Adenosine A2a Receptor antibody (ADORA2A) (C-Term)

Details for Product anti-ADORA2A Antibody No. ABIN1731565
Antigen
Epitope
C-Term, Cytoplasmic Domain
22
15
15
9
9
8
8
5
4
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Human
146
40
39
14
6
4
3
3
2
2
1
1
Host
Rabbit
117
24
7
1
Clonality
Polyclonal
Conjugate
This Adenosine A2a Receptor antibody is un-conjugated
6
5
5
3
3
3
3
3
3
3
2
2
2
1
1
1
1
1
1
Application
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
106
65
45
38
20
19
16
13
5
4
3
2
2
1
1
1
Options
Immunogen Synthetic 20 amino acid peptide from C-terminal cytoplasmic domain of human ADORA2A. Percent identity with other species by BLAST analysis: Human (100%), Gorilla, Gibbon, Monkey, Marmoset (95%), Dog (80%).
Isotype IgG
Specificity Reacts with human ADORA2A
Purification Antigen affinity purified
Antigen
Alternative Name ADORA2A (ADORA2A Antibody Abstract)
Background Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.
Gene ID 135
Pathways Neurotrophin Signaling Pathway, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints
Application Notes

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
IHC - P (10 μg/mL)

Restrictions For Research Use only
Format Liquid
Concentration 1 mg/mL
Buffer PBS, Sodium azide 0.1 %
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-80 °C
Storage Comment Long term: -70°C, Short term: +4°C
Supplier Images
Image no. 1 for anti-Adenosine A2a Receptor (ADORA2A) (C-Term), (Cytoplasmic Domain) antibody (ABIN1731565) anti-Adenosine A2a Receptor (ADORA2A) (C-Term), (Cytoplasmic Domain) antibody (Image 1)
Image no. 2 for anti-Adenosine A2a Receptor (ADORA2A) (C-Term), (Cytoplasmic Domain) antibody (ABIN1731565) anti-Adenosine A2a Receptor (ADORA2A) (C-Term), (Cytoplasmic Domain) antibody (Image 2)